Global Inflation Devices Market Outlook 2031: Surge in Cardiovascular Procedures to Propel Market Beyond US$ 851.8 Million at 5.2% CAGR

The global inflation devices market was valued at US$ 537.7 Mn in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2031, reaching more than US$ 851.8 Mn by the end of 2031. The steady expansion reflects the increasing volume of minimally invasive procedures and rising global burden of cardiovascular diseases (CVDs).

Historical data from 2017 to 2021 indicates consistent procedural growth, particularly in coronary and peripheral interventions, setting a solid foundation for the forecast period.

→Discover Market Opportunities - Request Your Sample Copy Now: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65861

→Analysts' Viewpoint

Analysts observe that the inflation devices market size is being fueled by the growing number of surgeries such as balloon angioplasty and arterial stent placement. Among display types, analog inflation devices remain dominant, while digital inflation devices are gaining attention for offering enhanced precision in inflation and deflation pressures.

Hospitals, specialty clinics, and ambulatory surgery centers are the primary end-users. Manufacturers can capitalize on the high incidence of cardiovascular diseases by designing portable and efficient devices suited for outpatient settings. The increasing usage of 30 ml pressure capacity inflation devices is closely linked to overall industry growth.

By application, the coronary interventions segment continues to expand due to technological advancements in interventional cardiology devices and evolving patient selection criteria for coronary revascularization.

→Market Overview

Inflation devices are critical medical instruments used to inflate balloons and stents during procedures across cardiovascular interventions, urology, gastroenterology, and ENT applications. Their primary role is to ensure controlled balloon expansion during procedures such as balloon angioplasty and arterial stent placement.

The market is witnessing growth driven by:

Rising surgical volumes globally
Increased adoption of minimally invasive techniques
Growing geriatric population
Expanding healthcare infrastructure in emerging economies

Rising prevalence of chronic diseases, particularly cardiovascular disorders
With healthcare systems shifting toward value-based care and outpatient efficiency, demand for compact, easy-to-use inflation systems is expected to intensify.

→Key Market Growth Drivers

1.Growth in Global CVD Prevalence

Cardiovascular diseases remain the leading cause of death worldwide, accounting for an estimated 13.7 million deaths in 2019. The aging global population significantly increases the number of individuals at risk of heart attacks, strokes, and peripheral artery disease.

Risk factors such as smoking, unhealthy diet, physical inactivity, hypertension, diabetes, and air pollution are contributing to the increasing incidence of CVDs. As the number of affected patients rises, so does the demand for interventional procedures that require inflation devices.

This expanding patient pool is directly influencing inflation devices market value growth through increased procedural volume.

2.Focus on Outpatient Care

Healthcare providers are increasingly shifting procedures from inpatient hospital settings to ambulatory surgery centers and specialty clinics. Outpatient procedures:

Reduce hospitalization costs
Improve patient convenience
Shorten recovery time
Lower resource utilization

Manufacturers are responding by designing portable and user-friendly balloon inflation devices optimized for outpatient environments. Devices with shorter setup times and simplified interfaces are gaining traction, thereby unlocking new market opportunities.

3.High Demand for Analog Inflation Devices

By display type, analog inflation devices dominated the market in 2022. These devices provide:

Reliable and consistent pressure control
Cost-effectiveness compared to digital systems
Simplified operation
Reduced maintenance requirements

Their affordability supports widespread adoption in hospitals and emerging healthcare facilities. Although digital devices offer higher precision, analog devices continue to dominate due to economic and operational advantages.

4.Balloon Angioplasty Gaining Traction

Balloon angioplasty remains one of the most commonly performed minimally invasive procedures for coronary and peripheral artery disease. Technological advancements in balloon materials have enhanced safety and effectiveness, reducing arterial wall damage and improving patient outcomes.

The increasing global prevalence of coronary artery disease is accelerating demand for balloon angioplasty, thereby strengthening the function-based segmentation of the inflation devices market.

5.Technological Advancements in Interventional Cardiology

Innovations in stents, catheters, and drug-coated balloons are expanding the scope of coronary interventions. Improved device compatibility and precision pressure regulation enhance procedural success rates, driving further adoption.

Peripheral interventions are also growing steadily due to rising awareness and improved diagnosis of peripheral arterial diseases.

→Market Challenges & Opportunities

1.Challenges

Regulatory compliance complexities
Pricing pressure in cost-sensitive markets
Competition from alternative technologies
Risk of procedural complications

2.Opportunities

Expansion into emerging economies in Asia Pacific and Latin America
Integration of digital pressure monitoring features
Development of disposable and single-use inflation devices
Growing ENT and gastroenterology applications
Increasing demand for 30 ml capacity devices
Manufacturers focusing on innovation and affordability are well-positioned to capitalize on these opportunities.

→Explore Strategies & Trends - Request Full Report Access - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=65861

→Market Segmentations

1.By Display Type

Analog Inflation Devices
Digital Inflation Devices
2.By Pressure Capacity

20 ml Inflation Devices
30 ml Inflation Devices
60 ml Inflation Devices

The 30 ml segment is witnessing significant growth due to its optimal balance between pressure capacity and procedural control.

3.By Function

Balloon Angioplasty
Arterial Stent Placement
Endoscopy
Others

4.By Application

Coronary Interventions
Urology
Gastroenterology
Peripheral Interventions
Others

Coronary interventions lead the application segment, supported by growing revascularization procedures.

5.By End-user

Hospitals
Specialty Clinics
Ambulatory Surgery Centers
6.Regions Covered

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

North America dominated the global industry in 2022 due to advanced healthcare infrastructure, strong regulatory frameworks, and higher procedural volumes. Asia Pacific is expected to witness robust growth during the forecast period owing to rising healthcare investments in China and India.

→Analysis of Key Players - Key Player Strategies

The competitive landscape is characterized by strong global and regional players focusing on portfolio expansion, mergers, acquisitions, and R&D investment.

Prominent players include:

Atrion Medical
BD
Lepu Medical Technology (Beijing) Co., Ltd.
Merit Medical Systems
Translumina
Advin Health Care
Dolphin Life Science India LLP
Boston Scientific Corporation
Acclarent, Inc. (Johnson & Johnson MedTech)
B. Braun Interventional Systems Inc.
CONMED Corporation
Cook Medical

→Key Player Strategies

Expanding product portfolios across multiple pressure capacities
Leveraging patented drug application technologies
Geographic expansion into high-growth emerging markets
Collaborations with healthcare institutions
Investment in digital monitoring technologies
Acquisitions to strengthen specialty portfolios
Companies are emphasizing innovation to enhance precision and safety, while also maintaining cost competitiveness.

→Recent Developments

In December 2023, Integra LifeSciences agreed to acquire Acclarent from Johnson & Johnson MedTech, part of J&J MedTech's Ethicon unit. The acquisition will enhance Integra's position in the ear, nose and throat (ENT) treatment market. Acclarent, part of J&J MedTech's Ethicon unit, offers groundbreaking balloon technologies for sinus dilation and eustachian tube dilation. The deal is expected to close by the second quarter of 2024 and will join Integra's Codman Specialty Surgical (CSS) division. The acquisition is expected to provide opportunities for collaboration between ENT and neurosurgeons on tumor care using skull base approaches.

In June 2023, Translumina acquired Dutch balloon catheter manufacturer Blue Medical Devices for an undisclosed sum. Established in 2013, Blue Medical manufactures balloon catheters, including drug-coated balloons (DCB) for complex coronary interventions. Translumina uses Blue Medical's patented drug application technology in other product lines, including neurovascular and peripheral interventions and drug coating recipes. Translumina is focusing on expanding its product portfolio, leveraging patented drug application technology, collaborating with healthcare institutions, expanding globally, and investing in talent and infrastructure.

→Investment Landscape and ROI Outlook

The inflation devices market presents a stable investment opportunity due to:

Predictable procedural growth
Aging demographics
Rising cardiovascular disease burden
Shift toward minimally invasive surgery

A CAGR of 5.2% through 2031 indicates steady returns rather than volatile growth. Investors targeting medical device portfolios with moderate risk profiles may find this sector attractive.

Emerging markets, particularly Asia Pacific and Latin America, offer high ROI potential due to expanding healthcare access and increasing procedural volumes.

→Why Buy This Report?

Comprehensive market size and forecast analysis (2017-2031)
Detailed segmentation by display type, pressure capacity, function, application, and end-user

Regional and country-level insights
Competitive landscape with market share analysis
Company profiles including financials, strategies, and recent developments
Qualitative insights including drivers, restraints, opportunities, and trend analysis

Porter's Five Forces and value chain analysis
Delivered in Electronic (PDF) + Excel format
Customization options are available upon request.

→FAQs

Q.How big was the global inflation devices market in 2022?

A.It was valued at US$ 537.7 Mn in 2022.

Q.How big will the inflation devices business be in 2031?

A.It is projected to reach more than US$ 851.8 Mn by the end of 2031.

Q.What will be the CAGR during 2023-2031?

A.The market is expected to grow at a CAGR of 5.2%.

Q.Which key trends are driving demand?

A.The primary trend is the growing demand for minimally invasive procedures to treat cardiovascular conditions.

Q.Which region will dominate the market?

A.North America is projected to account for a major share during the forecast period.

Buy Full Report Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=65861<ype=S

→Explore Latest Research Reports by Transparency Market Research:

In Vitro Fertilization Test Market: https://www.transparencymarketresearch.com/in-vitro-fertilization-test-market.html

Intrauterine Devices Market: https://admin.transparencymarketresearch.com/preview/report_detail1?rep_id=86611

Soft Tissue Repair Market: https://www.transparencymarketresearch.com/soft-tissue-repair-market.html

Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.